Contact Us
Email Us: Customer Service
Phone (US): 703-778-3080
Fax: 703-778-3081
-
Pay Invoice
Follow Us!
Latest Blogs
- How Market Research Supercharges Laboratory Diagnostics Go-To-Market Strategies April 24, 2024
- 4 Key Components to a Winning Go-To-Market Strategy April 24, 2024
- Immunoassays: A $27 Billion Market of Intrigue and Opportunity April 12, 2024
- IVD in Egypt: $440 Million Market Lead by Immunodiagnostic and Molecular Diagnostic Growth April 11, 2024
- Momentum in Multiplex Testing for IVD April 1, 2024
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
How Market Research Supercharges Laboratory Diagnostics Go-To-Market Strategies
In the dynamic laboratory diagnostics industry, staying ahead means having smart strategies in place. Market research is the secret ingredient that fuels successful go-to-market (GTM) plans. It helps you understand your audience, outshine competitors, and make informed decisions. In this blog, we explore how market research supercharges different parts of your GTM strategy for success […]
4 Key Components to a Winning Go-To-Market Strategy
Crafting a successful go-to-market (GTM) strategy in the laboratory diagnostic industry requires strategic planning and meticulous execution. It’s more than just bringing a product to market—it’s about aligning your offering with market needs, targeting the right audience, and positioning your brand for success. In this blog, we explore the essential steps and strategies necessary to […]
Immunoassays: A $27 Billion Market of Intrigue and Opportunity
The global market for lab-based immunoassays, inclusive of both infectious disease and non-infectious disease analytes and instruments, reached $27 billion in 2023 and is forecast to experience modest growth in the foreseeable future. The findings are based on data published in In Vitro Diagnostics Business Outlook, 2024, a bi-monthly newsletter focused on global IVD products […]
IVD in Egypt: $440 Million Market Lead by Immunodiagnostic and Molecular Diagnostic Growth
In Egypt, like many other countries, the elderly population is growing rapidly, increasing at a rate of 5.1% annually, which is more than double the growth rate of the total population. This demographic shift, coupled with a large rural population requiring satellite care and mobile services, poses significant challenges for the healthcare system, according to […]
Momentum in Multiplex Testing for IVD
Diagnostic testing is now a cornerstone of healthcare, assisting physicians in diagnosing conditions and prescribing treatments. Demand for in vitro diagnostic (IVD) testing has remained strong across various segments, with sales generally increasing throughout 2023. Global IVD market sales surpassed $100 billion in 2023, according to In Vitro Diagnostic (IVD) Trends and Market Update: March […]
Defining the Molecular Point of Care (mPOC) Market in 2024
Defining the molecular point of care (mPOC) market is the first step in market-sizing this segment. The mPOC market refers to the use of molecular diagnostic tests at or near the patient’s location to enable rapid and actionable clinical decisions. These tests typically involve the detection of nucleic acids (DNA or RNA) from pathogens or […]
Cancer, Obesity, Diabetes, and Cardiovascular Disease Drive South Korea’s IVD Investment
South Korea ranks as the fifth largest health market in the Asia Pacific region, following China, Japan, Australia, and India.. South Korea’s investment in healthcare, medical devices, and diagnostics is driven by the burden of obesity, diabetes, cardiovascular disease, and cancer. The country’s business environment for medical devices and equipment is favorable and streamlined for […]
Non-COVID-19 Vaccines Get Post-Pandemic Boost
Infectious diseases are some of the deadliest diseases that pose a significant risk to human life. Since the advent of the pandemic, scientists worldwide have intensified research and development of preventative vaccines that will hopefully combat existing and new infectious disease threats. Because of this dedicated focus, the global market for human preventive vaccines experienced […]
Medical Devices: A Clearer Look at X-Ray Imaging
The evolving healthcare landscape, influenced by factors such as expanded health insurance coverage from the Affordable Care Act, rising acute and chronic illness rates, and modernization of healthcare facilities, is driving growth in medical imaging products. While cost containment efforts may impact pricing, tests improving therapeutic outcomes are expected to thrive. In Kalorama Information’s report […]
Liquid Biopsy on Frontlines as Prostate Cancer Concerns Escalate
Each year, tens of thousands of men succumb to prostate cancer, a disease with an almost 100% survival rate when diagnosed early. According to a recent article by Fortune, rates of prostate cancer, America’s second-deadliest cancer in men, are on the rise. Since 2014, the U.S. has seen a 3% annual increase in diagnoses of […]